Medical Health & Life Science Research News

Injectable drug delivery market to reach USD 624.51 billion by 2021 according to new research report

Injectable Drug Delivery Market By Device Type (Self-injection Devices, Conventional Devices), By Formulation (Conventional Drug Delivery, Novel Drug Delivery), By Therapeutic Use (Autoimmune Disorders, Hormonal Disorders, Oncology), By End-user (Hospitals, Homecare Settings, Research Institutes, Clinical Laboratories), By Region

- Advertising -

According to the report Global Injectable Drug Delivery market, published by Market Data Forecast, the Market was worth USD 362.38 billion in 2016 and estimated to be growing at a CAGR of 11.5%, to reach USD 624.51 billion by 2021.

Injectable drug delivery technologies allow the transport of drugs detailed in fluid form and encourage the fast transport of the drug into the body. It likewise helps in managing drugs in comatose and unconscious patients.

These delivery frameworks are generally accepted because of their recognition of a faster onset reaction with high adequacy.

- Advertising -

 in the recent years, this market has developed because of the expanded predominance of cancer and diabetes.

Browse market data tables and in-depth TOC of the Global Injectable Drug Delivery Industry to 2021 at www.marketdataforecast.com/market-…very-market-2108/

The key factors driving the Injectable Drug Delivery Market are Increased prevalence of chronic diseases, Technological advances in the form of nanotechnologies, Rising demand for biologics in the pharmaceutical industry and Increased patient compliance. The Restraining factors affecting the IDD market include Possibility of injuries and infections via usage, Product recalls, Emergence of alternative drug delivery systems, Regulatory framework concerns.

Report: www.marketdataforecast.com/market-…08/request-sample

Injectable Drug Delivery Market is segmented into Device Type, Formulation, Therapeutic Use, End-user, Region. On the basis of Device type, the market is segmented into Self-Injection Devices, Conventional Devices.

On the basis of Formulation, the market is segmented into Conventional Drug Delivery, Novel Drug Delivery. On the basis of Therapeutic Use, market is divided into Autoimmune Disorders, Hormonal Disorders, Oncology.

On the basis of end user, the market is further divided into Hospitals, Homecare Settings, Research Institutes, Clinical Laboratories. On the basis of geography, the global market is analyzed under various regions namely North America, Europe, Asia-Pacific and Rest of the World.

Injectable Drug Delivery Market was dominated by North America, with the overall market share of over 35% globally. North America was followed by Europe and Asia-Pacific.

Asia Pacific is predicted to grow at a rapid pace in the coming few years.

Report: www.marketdataforecast.com/market-…/inquire

Some of the major companies dominating the market, by their products and services include Alkermes Inc., Bend Research, BIND Biosciences, Inc., Endocyte, Genentech Inc., MicroCHIPS, Inc., Pearl Therapeutics Inc., Polymer Factory, Presage Bioscience, QLT Inc., UCB Group.

 

News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...